Milne, C-P <br/><br/>
Impact of the new US health-care-reform legislation on the pharmaceutical industry: who are the real winners?  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Nov 2010 
 - 589-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2010.167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Budgets--legislation & jurisprudence<br/>Drug Industry--economics<br/>Economics, Pharmaceutical--legislation & jurisprudence<br/>Government Regulation<br/>Health Care Costs--legislation & jurisprudence<br/>Health Care Reform--economics<br/>Humans<br/>Organizational Objectives<br/>United States